Chinese General Practice ›› 2024, Vol. 27 ›› Issue (08): 908-914.DOI: 10.12114/j.issn.1007-9572.2023.0631
Special Issue: 内分泌代谢性疾病最新文章合集
• Original Research • Previous Articles Next Articles
Received:
2023-10-01
Revised:
2023-11-22
Published:
2024-03-15
Online:
2023-12-19
Contact:
ZHOU Min
通讯作者:
周敏
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0631
组别 | 例数 | 性别[例(%)] | 年龄( | 病程( | 职业[例(%)] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 工人 | 农民 | 企事业单位 | 退休人员 | 个体 | 未从事任何工作 | ||||
对照组 | 100 | 55(55.0) | 45(45.0) | 55.0±9.5 | 7.3±5.4 | 16(16.0) | 8(8.0) | 16(16.0) | 39(39.0) | 10(10.0) | 11(11.0) |
干预A组 | 100 | 67(67.0) | 33(33.0) | 52.2±10.2 | 6.4±5.4 | 10(10.0) | 9(9.0) | 24(24.0) | 33(33.0) | 11(11.0) | 13(13.0) |
干预B组 | 100 | 67(67.0) | 33(33.0) | 52.5±11.4 | 6.0±4.9 | 26(26.0) | 10(10.0) | 22(22.0) | 23(23.0) | 8(8.0) | 11(11.0) |
χ2(F)值 | 4.110 | 2.240a | 1.597a | 14.276 | |||||||
P值 | 0.128 | 0.108 | 0.204 | 0.161 | |||||||
组别 | 文化程度[例(%)] | 治疗方式[例(%)] | |||||||||
小学 | 初中 | 中专 | 高中 | 大专 | 本科 | 硕士生 | 博士生 | 口服降糖药 | 胰岛素治疗 | 口服降糖药+胰岛素治疗 | |
对照组 | 26(26.0) | 23(23.0) | 2(2.0) | 21(21.0) | 14(14.0) | 12(12.0) | 2(2.0) | 0 | 41(41.0) | 24(24.0) | 35(35.0) |
干预A组 | 21(21.0) | 13(13.0) | 5(5.0) | 21(21.0) | 16(16.0) | 19(19.0) | 4(4.0) | 1(1.0) | 47(47.0) | 24(24.0) | 29(29.0) |
干预B组 | 22(22.0) | 22(22.0) | 2(2.0) | 18(18.0) | 15(15.0) | 18(18.0) | 3(3.0) | 0 | 46(46.0) | 30(30.0) | 24(24.0) |
χ2(F)值 | 10.602 | 3.454 | |||||||||
P值 | 0.717 | 0.485 | |||||||||
组别 | 婚姻状态[例(%)] | 家庭月收入[例(%)] | |||||||||
已婚 | 未婚 | 离异 | 丧偶 | <2 000元 | 2 000~元 | 5 000~元 | >10 000元 | ||||
对照组 | 91(91.0) | 2(2.0) | 2(2.0) | 5(5.0) | 10(10.0) | 47(47.0) | 35(35.0) | 8(8.0) | |||
干预A组 | 89(89.0) | 4(4.0) | 3(3.0) | 4(4.0) | 10(10.0) | 40(40.0) | 37(37.0) | 13(13.0) | |||
干预B组 | 93(93.0) | 4(4.0) | 0 | 3(3.0) | 16(16.0) | 44(44.0) | 27(27.0) | 13(13.0) | |||
χ2(F)值 | 4.188 | 5.732 | |||||||||
P值 | 0.651 | 0.454 |
Table 1 Comparison of general information in three groups of T2DM patients
组别 | 例数 | 性别[例(%)] | 年龄( | 病程( | 职业[例(%)] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | 工人 | 农民 | 企事业单位 | 退休人员 | 个体 | 未从事任何工作 | ||||
对照组 | 100 | 55(55.0) | 45(45.0) | 55.0±9.5 | 7.3±5.4 | 16(16.0) | 8(8.0) | 16(16.0) | 39(39.0) | 10(10.0) | 11(11.0) |
干预A组 | 100 | 67(67.0) | 33(33.0) | 52.2±10.2 | 6.4±5.4 | 10(10.0) | 9(9.0) | 24(24.0) | 33(33.0) | 11(11.0) | 13(13.0) |
干预B组 | 100 | 67(67.0) | 33(33.0) | 52.5±11.4 | 6.0±4.9 | 26(26.0) | 10(10.0) | 22(22.0) | 23(23.0) | 8(8.0) | 11(11.0) |
χ2(F)值 | 4.110 | 2.240a | 1.597a | 14.276 | |||||||
P值 | 0.128 | 0.108 | 0.204 | 0.161 | |||||||
组别 | 文化程度[例(%)] | 治疗方式[例(%)] | |||||||||
小学 | 初中 | 中专 | 高中 | 大专 | 本科 | 硕士生 | 博士生 | 口服降糖药 | 胰岛素治疗 | 口服降糖药+胰岛素治疗 | |
对照组 | 26(26.0) | 23(23.0) | 2(2.0) | 21(21.0) | 14(14.0) | 12(12.0) | 2(2.0) | 0 | 41(41.0) | 24(24.0) | 35(35.0) |
干预A组 | 21(21.0) | 13(13.0) | 5(5.0) | 21(21.0) | 16(16.0) | 19(19.0) | 4(4.0) | 1(1.0) | 47(47.0) | 24(24.0) | 29(29.0) |
干预B组 | 22(22.0) | 22(22.0) | 2(2.0) | 18(18.0) | 15(15.0) | 18(18.0) | 3(3.0) | 0 | 46(46.0) | 30(30.0) | 24(24.0) |
χ2(F)值 | 10.602 | 3.454 | |||||||||
P值 | 0.717 | 0.485 | |||||||||
组别 | 婚姻状态[例(%)] | 家庭月收入[例(%)] | |||||||||
已婚 | 未婚 | 离异 | 丧偶 | <2 000元 | 2 000~元 | 5 000~元 | >10 000元 | ||||
对照组 | 91(91.0) | 2(2.0) | 2(2.0) | 5(5.0) | 10(10.0) | 47(47.0) | 35(35.0) | 8(8.0) | |||
干预A组 | 89(89.0) | 4(4.0) | 3(3.0) | 4(4.0) | 10(10.0) | 40(40.0) | 37(37.0) | 13(13.0) | |||
干预B组 | 93(93.0) | 4(4.0) | 0 | 3(3.0) | 16(16.0) | 44(44.0) | 27(27.0) | 13(13.0) | |||
χ2(F)值 | 4.188 | 5.732 | |||||||||
P值 | 0.651 | 0.454 |
组别 | 例数 | FBG( | 2 hPG( | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | ||
对照组 | 100 | 10.56±0.49 | 8.18±0.31 | 7.39±0.21 | 6.99±0.18 | 6.86±0.18 | 13.60±0.45 | 10.73±0.29 | 9.79±0.24 | 9.21±0.21 | 8.90±0.18 |
干预A组 | 100 | 10.57±0.45 | 7.96±0.29 | 7.45±0.25 | 7.14±0.21 | 6.86±0.17 | 14.82±0.48 | 10.43±0.28 | 9.55±0.25 | 8.92±0.19 | 8.67±0.15 |
干预B组 | 100 | 10.40±0.54 | 7.89±0.24 | 7.51±0.43 | 6.36±0.13ab | 5.99±0.11ab | 14.18±0.66 | 10.74±0.35 | 8.95±0.27a | 8.11±0.14ab | 7.47±0.14ab |
检验统计量值 | F交互=14.365,F组间=1.792,F时间=241.733 | F交互=20.922,F组间=3.845,F时间=397.933 | |||||||||
P值 | P交互=0.073,P组间=0.408,P时间<0.001 | P交互=0.007,P组间=0.146,P时间<0.001 | |||||||||
组别 | HbA1c( | 低血糖发生次数[M(QR),次] | |||||||||
T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | ||
对照组 | 8.50±0.23 | 7.31±0.17 | 7.11±0.14 | 6.98±0.12 | 6.89±0.11 | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | |
干预A组 | 9.03±0.23 | 7.75±0.15 | 7.15±0.12 | 6.75±0.90 | 6.59±0.50a | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | |
干预B组 | 8.89±0.22 | 7.58±0.20 | 7.40±0.18 | 7.24±0.16b | 6.32±0.10ab | 0(0) | 0(0)ab | 0(0) | 0(0) | 0(0)b | |
检验统计量值 | F交互=68.345,F组间=0.452,F时间=327.230 | χ2交互=26.400,χ2组间=1.672,χ2时间=4.966 | |||||||||
P值 | P交互<0.001,P组间=0.808,P时间<0.001 | P交互=0.001,P组间=0.433,P时间=0.291 |
Table 2 Comparison of FBG,2 hPG,HbA1c,and number of hypoglycemic episodes at T0,T1,T2,T3,and T4 in three groups of patients with T2DM
组别 | 例数 | FBG( | 2 hPG( | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | ||
对照组 | 100 | 10.56±0.49 | 8.18±0.31 | 7.39±0.21 | 6.99±0.18 | 6.86±0.18 | 13.60±0.45 | 10.73±0.29 | 9.79±0.24 | 9.21±0.21 | 8.90±0.18 |
干预A组 | 100 | 10.57±0.45 | 7.96±0.29 | 7.45±0.25 | 7.14±0.21 | 6.86±0.17 | 14.82±0.48 | 10.43±0.28 | 9.55±0.25 | 8.92±0.19 | 8.67±0.15 |
干预B组 | 100 | 10.40±0.54 | 7.89±0.24 | 7.51±0.43 | 6.36±0.13ab | 5.99±0.11ab | 14.18±0.66 | 10.74±0.35 | 8.95±0.27a | 8.11±0.14ab | 7.47±0.14ab |
检验统计量值 | F交互=14.365,F组间=1.792,F时间=241.733 | F交互=20.922,F组间=3.845,F时间=397.933 | |||||||||
P值 | P交互=0.073,P组间=0.408,P时间<0.001 | P交互=0.007,P组间=0.146,P时间<0.001 | |||||||||
组别 | HbA1c( | 低血糖发生次数[M(QR),次] | |||||||||
T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | ||
对照组 | 8.50±0.23 | 7.31±0.17 | 7.11±0.14 | 6.98±0.12 | 6.89±0.11 | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | |
干预A组 | 9.03±0.23 | 7.75±0.15 | 7.15±0.12 | 6.75±0.90 | 6.59±0.50a | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | |
干预B组 | 8.89±0.22 | 7.58±0.20 | 7.40±0.18 | 7.24±0.16b | 6.32±0.10ab | 0(0) | 0(0)ab | 0(0) | 0(0) | 0(0)b | |
检验统计量值 | F交互=68.345,F组间=0.452,F时间=327.230 | χ2交互=26.400,χ2组间=1.672,χ2时间=4.966 | |||||||||
P值 | P交互<0.001,P组间=0.808,P时间<0.001 | P交互=0.001,P组间=0.433,P时间=0.291 |
组别 | 例数 | TC | TG | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | ||
对照组 | 100 | 5.38±0.13 | 5.15±0.13 | 5.01±0.13 | 4.91±0.13 | 4.78±0.13 | 2.63±0.31 | 2.52±0.29 | 2.44±0.28 | 2.34±0.26 | 2.30±0.26 |
干预A组 | 100 | 5.05±0.13 | 4.93±0.13 | 4.80±0.13 | 4.56±0.12a | 4.41±0.12a | 2.55±0.29 | 2.50±0.25 | 2.96±0.76 | 2.11±0.19 | 2.20±0.17 |
干预B组 | 100 | 5.06±0.11 | 4.89±0.91 | 4.67±0.88a | 4.44±0.10a | 4.28±0.93a | 2.95±0.73 | 2.13±0.15 | 2.16±0.17 | 1.94±0.14 | 1.81±0.13 |
F值 | F交互=14.802,F组间=6.245,F时间=176.993 | F交互=14.654,F组间=0.886,F时间=23.133 | |||||||||
P值 | P交互=0.063,P组间=0.044,P时间<0.001 | P交互=0.066,P组间=0.642,P时间<0.001 | |||||||||
组别 | LDL-C | HDL-C | |||||||||
T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | ||
对照组 | 3.12±0.11 | 2.98±0.11 | 2.91±0.11 | 2.83±0.11 | 2.78±0.11 | 1.20±0.43 | 1.22±0.42 | 1.21±0.39 | 1.23±0.40 | 1.25±0.44 | |
干预A组 | 2.89±0.10 | 2.90±0.12 | 2.82±0.12 | 2.68±0.10 | 2.58±0.10 | 1.32±0.50 | 1.31±0.44 | 1.34±0.47a | 1.38±0.49a | 1.40±0.52a | |
干预B组 | 2.93±0.98 | 2.85±0.97 | 2.70±0.86 | 2.63±0.97 | 2.49±0.91a | 1.28±0.43 | 1.33±0.41a | 1.39±0.39a | 1.46±0.40a | 1.53±0.42ab | |
F值 | F交互=10.946,F组间=2.351,F时间=100.171 | F交互=18.499,F组间=11.501,F时间=44.622 | |||||||||
P值 | P交互=0.205,P组间=0.309,P时间<0.001 | P交互=0.018,P组间=0.003,P时间<0.001 |
Table 3 Comparison of TC,TG,LDL -C and HDL-C at T0,T1,T2,T3 and T4 in three groups of patients with T2DM
组别 | 例数 | TC | TG | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | ||
对照组 | 100 | 5.38±0.13 | 5.15±0.13 | 5.01±0.13 | 4.91±0.13 | 4.78±0.13 | 2.63±0.31 | 2.52±0.29 | 2.44±0.28 | 2.34±0.26 | 2.30±0.26 |
干预A组 | 100 | 5.05±0.13 | 4.93±0.13 | 4.80±0.13 | 4.56±0.12a | 4.41±0.12a | 2.55±0.29 | 2.50±0.25 | 2.96±0.76 | 2.11±0.19 | 2.20±0.17 |
干预B组 | 100 | 5.06±0.11 | 4.89±0.91 | 4.67±0.88a | 4.44±0.10a | 4.28±0.93a | 2.95±0.73 | 2.13±0.15 | 2.16±0.17 | 1.94±0.14 | 1.81±0.13 |
F值 | F交互=14.802,F组间=6.245,F时间=176.993 | F交互=14.654,F组间=0.886,F时间=23.133 | |||||||||
P值 | P交互=0.063,P组间=0.044,P时间<0.001 | P交互=0.066,P组间=0.642,P时间<0.001 | |||||||||
组别 | LDL-C | HDL-C | |||||||||
T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | ||
对照组 | 3.12±0.11 | 2.98±0.11 | 2.91±0.11 | 2.83±0.11 | 2.78±0.11 | 1.20±0.43 | 1.22±0.42 | 1.21±0.39 | 1.23±0.40 | 1.25±0.44 | |
干预A组 | 2.89±0.10 | 2.90±0.12 | 2.82±0.12 | 2.68±0.10 | 2.58±0.10 | 1.32±0.50 | 1.31±0.44 | 1.34±0.47a | 1.38±0.49a | 1.40±0.52a | |
干预B组 | 2.93±0.98 | 2.85±0.97 | 2.70±0.86 | 2.63±0.97 | 2.49±0.91a | 1.28±0.43 | 1.33±0.41a | 1.39±0.39a | 1.46±0.40a | 1.53±0.42ab | |
F值 | F交互=10.946,F组间=2.351,F时间=100.171 | F交互=18.499,F组间=11.501,F时间=44.622 | |||||||||
P值 | P交互=0.205,P组间=0.309,P时间<0.001 | P交互=0.018,P组间=0.003,P时间<0.001 |
组别 | 例数 | 2-DSCS评分 | SDSCA评分 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | ||
对照组 | 100 | 19.44±1.06 | 35.47±1.88 | 41.02±1.56 | 46.42±1.28 | 53.59±1.01 | 52.28±1.90 | 64.35±1.57 | 76.26±0.91 | 86.18±0.85 | 91.49±0.13 |
干预A组 | 100 | 17.55±1.21 | 35.16±1.70 | 45.08±0.92a | 50.27±0.71a | 57.60±0.97a | 54.15±0.84 | 70.37±0.12a | 78.95±0.69a | 84.09±0.92 | 93.22±0.12 |
干预B组 | 100 | 20.04±0.41 | 38.51±1.38 | 46.84±0.90a | 55.27±0.51ab | 61.50±0.45ab | 51.28±0.13 | 70.57±0.21a | 81.80±0.96ab | 90.70±0.96ab | 97.04±0.11ab |
F值 | F交互=99.477,F组间=22.097,F时间=3 604.223 | F交互=39.552,F组间=16.552,F时间=1 437.641 | |||||||||
P值 | P交互<0.001,P组间<0.001,P时间<0.001 | P交互<0.001,P组间<0.001,P时间<0.001 |
Table 4 Comparison of 2-DSCS and SDSCA scores at T0,T1,T2,T3 and T4 in three groups of T2DM patients
组别 | 例数 | 2-DSCS评分 | SDSCA评分 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
T0 | T1 | T2 | T3 | T4 | T0 | T1 | T2 | T3 | T4 | ||
对照组 | 100 | 19.44±1.06 | 35.47±1.88 | 41.02±1.56 | 46.42±1.28 | 53.59±1.01 | 52.28±1.90 | 64.35±1.57 | 76.26±0.91 | 86.18±0.85 | 91.49±0.13 |
干预A组 | 100 | 17.55±1.21 | 35.16±1.70 | 45.08±0.92a | 50.27±0.71a | 57.60±0.97a | 54.15±0.84 | 70.37±0.12a | 78.95±0.69a | 84.09±0.92 | 93.22±0.12 |
干预B组 | 100 | 20.04±0.41 | 38.51±1.38 | 46.84±0.90a | 55.27±0.51ab | 61.50±0.45ab | 51.28±0.13 | 70.57±0.21a | 81.80±0.96ab | 90.70±0.96ab | 97.04±0.11ab |
F值 | F交互=99.477,F组间=22.097,F时间=3 604.223 | F交互=39.552,F组间=16.552,F时间=1 437.641 | |||||||||
P值 | P交互<0.001,P组间<0.001,P时间<0.001 | P交互<0.001,P组间<0.001,P时间<0.001 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
张鲁敏,任皎皎,范蓓蓉,等. 健康教练技术对COPD患者自我管理能力及肺功能的影响[J]. 护理学报,2023,30(6):72-78. DOI:10.16460/j.issn1008-9969.2023.06.072.
|
[9] |
|
[10] |
|
[11] |
|
[12] |
王璟璇,王瑞霞,林秋菊. 门诊诊断初期非胰岛素依赖型糖尿病患者的自我照顾行为及其相关因素之探讨 [J]. 护理杂志,1998,45(2):60-74.
|
[13] |
|
[14] |
万巧琴,尚少梅,来小彬,等. 2型糖尿病患者自我管理行为量表的信、效度研究[J]. 中国实用护理杂志,2008,24(7):26-27. DOI:10.3760/cma.j.issn.1672-7088.2008.07.009.
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [M/OL].[2023-02-02].
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[1] | ZHANG Yong, WANG Senli, HUANG Ronghua, XU Fengping, LIU Dan. Intervention Effect of Music Therapy on Patients with Alzheimers Disease: a Meta-analysis [J]. Chinese General Practice, 2024, 27(12): 1511-1518. |
[2] | ZHENG Rong, LIU Zhidong, WANG Miao, ZHANG Xiao, CHEN Junlan, ZHOU Shigao. A Randomized Controlled Study on Gehu Tiaozhi Decoction Intervening Patients with Metabolic Syndrome [J]. Chinese General Practice, 2024, 27(03): 343-347. |
[3] | YAO lin, SHANG Danmei, ZHAO Hui, LIU Xinyu, LIU Yongwei, JIANG Yong. The Effect and Satisfaction of Mobile Network in the Hypertension Management of Community-dwelling Older Adults [J]. Chinese General Practice, 2024, 27(01): 85-90. |
[4] | YAO Yuzhong, MA Xiaojun, SONG Huan, ZHONG Yu. The Management Effect of Diabetes "1358 model" on Community Diabetes Patients Based on "Precision Management Combining General Care and Specialty Care" [J]. Chinese General Practice, 2023, 26(34): 4308-4314. |
[5] | LI Qian, ZHANG Yunshu, YAN Baoping, WANG Jian, MA Yanjuan, WANG Yuan, QIN Yingjie, NA Long, REN Zhiyong, SUN Junwei, DENG Huaili, MA Hongjun, QU Xuehui, ZHOU Nan, SI Tianmei. Efficacy and Safety of Risperidone Microspheres for Injection (Ⅱ) in the Treatment of Patients with Acute Schizophrenia [J]. Chinese General Practice, 2023, 26(32): 4007-4012. |
[6] | LIU Minghao, WANG Pan, GAO Lijian, XU Shuqing, WANG Huanhuan, ZHAO Guangxian, CHEN Jue, QIAO Shubin, XU Bo, YUAN Jinqing. Feasibility, Safety and Timing of Secondary Percutaneous Coronary Intervention via Distal Transradial Artery Approach [J]. Chinese General Practice, 2023, 26(27): 3366-3372. |
[7] | YAO Junjie, SHANG Qiangqiang, WANG Yufeng, LI Jiahui, LIU Chang, PANG Tingting. Wearable Inertial Sensors-based Efficacy Evaluation of Comprehensive Traditional Chinese Medicine Therapy for Lumbar Disc Herniation Due to Qi-stagnation and Blood-stasis [J]. Chinese General Practice, 2023, 26(27): 3450-3455. |
[8] | LU Bin, XIANG Chong, YUAN Xuesong, CAI Gaojun, WEI Wenfeng, YAN Yongmin. Effectiveness, Safety and Satisfaction of Distal Transradial Artery Approach in Cerebral Angiography [J]. Chinese General Practice, 2023, 26(27): 3378-3382. |
[9] | GAO Yang, WANG Yunxia, GAO Chuanyu. Familial Hypercholesterolemia in 45-year-old and Younger Patients with Acute Coronary Syndrome: Clinical Characteristics and Influencing Factors of Blood Lipid Control Effect [J]. Chinese General Practice, 2023, 26(18): 2232-2237. |
[10] | FANG Fusheng, LIU Xingyu, YAN Shuangtong, WANG Ning, LI Chunlin, TIAN Hui. Relationship between Time in Range and Long-term HbA1c Glycemic Variability in Elderly Male Patients with Type 2 Diabetes [J]. Chinese General Practice, 2023, 26(16): 1979-1983. |
[11] | YANG Bei, HAN Lin, WANG Yin, CHENG Kangyao. Effectiveness of Continuous Subcutaneous Insulin Injection in Type 2 Diabetes in Older Adults: a Meta-analysis and Trial Sequential Analysis [J]. Chinese General Practice, 2023, 26(15): 1892-1901. |
[12] | WANG Lingxiao, DONG Rongna, ZHOU Bing, GUO Lina, LI Jing. Analysis of the Effect of Human-computer Interaction Intelligent Management on Blood Glucose Control in New-onset Type 2 Diabetes Mellitus Patients [J]. Chinese General Practice, 2023, 26(15): 1817-1823. |
[13] | LIU Chuanfen, LI Zheng, WU Manyan, CUI Yuxia, SONG Jing, ZHANG Chunying, CHEN Hong. Analysis of Serum Lipid Level and Drug Use in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(11): 1325-1329. |
[14] | FEI Jingwen, LIN Huize, ZHANG Pingping, LIU Lanping, WANG Xiang, SHEN Jianghong, ZHU Kexin, YANG Tao, YU Jinna. Motion Style Acupuncture Can Effectively Improve the Effectiveness of Acute Nonspecific Low Back Pain: a Meta-analysis [J]. Chinese General Practice, 2023, 26(09): 1044-1052. |
[15] | GUAN Ningxiao, YAO Zhuoya, LI Ye, LIU Ziwei, LIU Fangli. Non-invasive Brain Stimulation Techniques Can Effectively Relieve Post-stroke Fatigue: a Meta-analysis [J]. Chinese General Practice, 2023, 26(08): 1008-1014. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||